Chief Financial Officer

Senior Vice President CMC Development

Alnylam price target raised by $54 at Stifel, here's why

Alnylam begins global Phase 3 trial dosing of zilebesiran

Cambridge-based Alnylam Pharmaceuticals pulls TV ad after Trump crackdown on drug industry spots

Alnylam Pharmaceuticals Insider Sold Shares Worth $4,034,085, According to a Recent SEC Filing

Business Account Executive

Alnylam Pharmaceuticals is a leader in RNAi therapeutics, seeking experienced Business Account Executives to promote AMVUTTRA™. The role involves targeting healthcare providers, developing account strategies, and increasing brand awareness for TTR amyloidosis treatment within the assigned territory.

Business Account Executive, TTR - Phoenix North, AZ

Associate Director - Business Account Executive (Rare Disease)

Business Account Executive Rare Disease

Business Account Executive - Rare Diseases (PH1 & AHP)

Business Account Executive-Ultra Rare Disease- PH1- Neph/Uro/Ped. Neph/Ped. Ur/AHP-Hem/Oncs/Gastros 

Sign up with Google

Sign in with Google